Clinical Trial Update: Long-term Safety and Efficacy of MEDITOXIN® in Treatment Glabellar Lines [Phase 4]

View source ↗

Summary

Phase 4 trial update on long-term safety and efficacy of MEDITOXIN® for glabellar lines.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glabellar Frown Lines

Drugs mentioned

• Meditoxin (botulinum toxin type A)

Snippet

Sponsor: Medy-Tox | Conditions: Glabellar Frown Lines | Phase 4 | Status: COMPLETED